← All stocks

Phio Pharmaceuticals Corp.

PHIO Net buying
CIK 0001533040 #5173 in the set updated 17 Sep 2026
Bought (1 mo)
$40.06K
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$40.06K
+$40.06K against sales at will

By person

8 insiders · 3 transactions
0.8×

Robert J. Bitterman holds only 0.8 times base salary in stock. $373.76K of shares against $419.05K in salary for 2025.

Salary from the company's own proxy. The shares are what Robert J. Bitterman last reported holding, valued at $1.03, the price Common Stock, $.0001 par value was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Plott Ronald Todd
Director
$17.10K (1)
+$17.10K
15,000
$15.45K
BRADFORD PATRICIA A
Director
$12.36K (1)
+$12.36K
57,651
$59.38K
+590.3%
Bitterman Robert J
Chairman, Pres. & CEO
$10.60K (1)
+$10.60K
362,871
$373.76K
+1,935%
Carson Lisa Cabott
Chief Financial Officer
81,112
$83.55K
Ferrara Robert L
Director
38,666
$39.83K
+262.5%
Deming David H
Director
37,800
$38.93K
Lockshin Curtis
Director
35,155
$36.21K
+1,393%
Freeman Jonathan E
Director
32,655
$33.63K
+2,310%

No percentages here. This company's share count has moved by a factor of 11.0 over the window, from 1,055,219 to 11,617,250 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 5
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 81,438
History held since 20 Dec 2016